Interferon-β therapy for malignant melanoma: The dose is crucial for inhibition of proliferation and induction of apoptosis of melanoma cells

Archives of Dermatological Research

Volumn 300, Issue 6, 2008, Pages 297-301

  Kubo, Hitomi ^a   Ashida, Atsuko ^a   Matsumoto, Kazuhiko ^a,b   Kageshita, Toshiro ^c   Yamamoto, Akifumi ^d   Saida, Toshiaki ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Growth inhibition; Human melanoma cell; Interferon(IFN)

Indexed keywords

BETA INTERFERON;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; SKIN METASTASIS;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; INTERFERON-BETA; MELANOMA; NEOPLASM METASTASIS; SKIN NEOPLASMS; VACCINATION;

EID: 46649113134     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0841-6     Document Type: Article

References (19)

1. Albini A, Marchisone C, Del Grosso F, Benelli R, Masiello L, Tacchetti C et al (2000) Inhibition of angiogenesis and vascular tumor growth by interferon producing cells: A gene therapy approach. Am J Pathol 156:1381-1393
2. Byers HR, Etoh T, Doherty RJ, Sober JA, Mihm CM Jr (1991) Cell migration and actin organization in cultured human primary, reccurent cutaneous and metastatic melanoma. Am J Pathol 139:423-435
3. Chawla-Sarkar M, Leaman DW, Borden EC (2001) Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2. Clin Cancer Res 7:1821-1831
4. Chawla-Sarkar M, Leaman DW, Jacobs BS, Borden EC (2002) IFN-beta pretreatment sensitizes human melanoma cells to TRAIL/Apo2 ligand-indeced apoptosis. J Immunol 169:847-855
5. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A (1995) Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. Genes Dev 9:15-30
6. Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W et al (1999) Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta. Cancer Res 59:872-879
7. Garbe C, Krasagakis K, Zouboulis CC, Schroder K, Kruger S, Stadler R et al (1990) Antitumor activities of interferon alpha, beta, and gamma and their combinations on human melanoma cells in vitro: changes of proliferation, melanin synthesis, and immunophenotype. J Invest Dermatol 95:231s-237s
8. Garbe C (1993) Chomotherapy and chemoimmunotherapy in disseminated malignant melanoma. Melanoma Res 3:291-299
9. Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS et al (2000) Efficient inhibition in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res 6:3354-3360
10. Horikoshi T, Fukuzawa K, Hanada N, Ezoe K, Eguchi H, Hamaoka S et al (1995) In vitro comparative study of the antitumor effects of human interferon-alpha, beta, and gamma on the growth and invasive potential of human melanoma cells. J Dermatol 22:631-636
11. Johns TG, Mackay IR, Callister KA, Hertzog PJ, Devenish RJ, Linnane AW (1992) Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon β. J Natl Cancer Inst 84(15):1185-1190
12. Kikuchi K, Nakagawa H, Kondo T, Etoh T, Byers HR, Mihm CM Jr et al (1996) Decreased ETB receptor expression in human metastatic melanoma cells. Biochem Biophys Res Commun 219:734-739
13. Kopf I, Hanson C, Delle U, Weimarck A, Stierner U (1996) Action of interferon alpha and beta on four human melanoma cell lines in vitro. Anticancer Res 16(2):791-798
14. Liu T, Biddle D, Hanks AN, Brouha B, Yan H, Lee RM et al (2006) Activation of dual apoptotic pathways in human melanocytes and protection by Survivin. J Invest Dermatol 126:2247-2256
15. Nagatani T, Ichiyama S, Onuma R, Miyazawa M, Matsuzaki T, Miyagawa K et al (1995) The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma. Acta Derm Venerol 75:494
16. Qin X Q, Runkel L, Deck C, DeDios C, Barsoum J (1997) Interferon-beta induces S phase accumulation selectively in human transformed cells. J Interferon Cytokine Res 17:355-367
17. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227-264
18. von Stamm U, Brocker EB, von Depka Prondzinski M, Ruiter DJ, Rumke P, Broding C et al (1993) Effects of systemic interferon-alpha(IFN-alpha) on the antigenic phenotype of melanoma metastases. EORTC Melanoma Group Cooperative Study No. 18852. Melanoma Res 3:173-180
19. Zhang H, Koty PP, Mayotte J, Levitt ML (1999) Induction of multiple programmed cell death pathways by IFN-beta in human non-small-cell lung cancer cell lines. Exp Cell Res 247:133-141